Stroke Trial, Recruiting NCT07185971 Sponsor: NeuroAEye LLC Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07185971
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke, traumatic brain injury, or brain surgery — at least 6 months ago but no more than 10 years ago
  • People who have been formally diagnosed with a specific type of vision loss affecting one side or one quarter of their visual field, or a general narrowing of their overall field of vision

Who may not be able to join:

  • People with a physical, neurological, or mental condition that would interfere with receiving the treatment
  • People who are currently using another vision therapy
  • People who are currently taking certain medications that may affect training, such as amphetamines or dopamine-related drugs (confirm with trial site)
  • People with certain eye or brain conditions that would interfere with training or cause additional vision problems, including having no remaining vision at all, certain eye disorders, or specific types of visual field loss not related to the optic nerve
  • People who are unable to hold a steady gaze (confirm with trial site)
  • People who depend on a life-supporting external medical device, such as an infusion pump or a heart assist device
  • People who have an active implanted medical device, such as a pacemaker, defibrillator, nerve stimulator, or cochlear implant
  • People with a known history of epilepsy triggered by light or flashing images
  • People who have an active, ongoing infection on the head or face
  • People with a known immune disorder where an infection could be life-threatening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: DeAnn Fitzgerald, Doctor of Optometry, Dr. D. M. Fitzgerald & Associates

Phone: 315-730-9842

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NeuroAEye LLC
Registry
ClinicalTrials.gov
Start date
16 March 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Population Mean Change in Visual Field Area

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov